ASH · Automatic Sample Handler

Reliable blood samples. No matter who takes them.

ASH automates the finger prick. It draws a precise blood sample and loads it straight into the test you already use.

See how it works Get in touch

Prototype in development · Copenhagen, Denmark

Concept render of ASH taking a finger-prick blood sample
1 in 8manual finger-prick samples shows moderate to severe hemolysis.¹
Every drawthe same depth and the same volume, logged automatically.
Anyonecan use it. A nurse, an assistant, or the patient at home.

¹ Parikh & Berube, Clinical Chemistry 69 (Suppl. 1), 2023. Conventional capillary collection by trained staff: 12.3% moderate or gross hemolysis.

The problem

A finger prick looks simple. It isn't.

The test is certified. The sample isn't. Its quality depends on the hands that took it.

Hemolysis

Squeezing the finger bursts red blood cells and skews the result.

Wrong volume

Too much or too little blood means a failed or misleading test.

No record

When a sample goes wrong, nobody knows why. Nothing is logged.

So we took the guesswork out of the finger prick.

How it works

Place your finger. ASH does the rest.

Five automated steps. The same every time.

No new analyser neededWorks with the certified tests clinics already run, like CRP, glucose and HbA1c.

Every draw leaves a recordSampling and quality data are logged automatically.

  1. Positions the finger

    A guide holds it in the right place.

  2. Lances

    A single-use lancet. Same depth every time.

  3. Detects the blood

    Sensors check the drop before collecting.

  4. Measures

    Draws an exact volume. No squeezing.

  5. Loads the test

    Sealed transfer into the test cartridge or strip.

Where it fits

From the clinic to the kitchen table

Concept render of a patient using an ASH station in a clinic waiting room

In the clinic

Patients can do the blood draw themselves, semi-supervised. Your nurses get their time back.

Concept render of a woman using a compact ASH device at her dining table

At home

Simple enough for patients to use themselves. Fewer trips to the doctor.

Where we are

Early prototype. Clear next steps.

Now

Prototype

Core subsystems in active development.

Next

Biosafe prototype

Validate reliability, volume control and safety.

Then

Pilot

First clinical data in supervised settings.

In parallel

Regulatory

Certification strategy built with experts.

Our team

Meet Desentra

Rógvi Ziskason

CEO, co-founder

Birni Sigvardsen

COO, co-founder

Kristin Dahl Rasmussen

CTO, co-founder

Advisory board

Lennart Jan Friis-Hansen

Researcher and Senior Physician, Clinical Biochemistry, Odense University Hospital

Nicholas Francis

Co-founder, Unity

Let's talk.

Investor, clinician or potential partner? We'd love to hear from you.

Rógvi Ziskason, CEO